 Home > Medical News > Medical World News > Lutathera, Novartic's treatment of neuroendocrine tumors, is FDA approved

Lutathera, Novartic's treatment of neuroendocrine tumors, is FDA approved

 Last Update: 2021-02-20
 Source: Internet
 Author: User

Tags

woodland group llc

group enterococcus

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Neuroendocrine tumor (NETs) is a rare type of tumor that can develop in the gastrointestinal tract, pancreas, lungs and many other organs of neuroendocrine cells.
recently, the FDA announced that it had approved Lutathera (Lutetium Lu 177 dotatate) of Novart Group Inc.'s Advanced Accelerator Applications to treat gastrointestinal pancreatic neuroendocrine tumors (GEP-NETs) that are positive for growth inhibitor.about Luthera
Lutathera is a radioactive drug that binds to growth inhibitor inhibitor on the surface of tumor cells and enters the cells, causing damage to tumor cells through radioactivity.
previously, Lutathera had been eligible for FDA orphan drugs and had been eligible for priority review.study
Lutathera's efficacy was validated in two key Phase 3 clinical trials.
in the first trial, combined with the best standard care (30mg octreotide LA every four weeks), Lutathera showed good results, reducing the risk of disease progress or death by 79% (HR 0.21, 95% CI:0.13-0.) 32< p<0.001);
In the second trial, Lutathera had 16 percent of the 1,214 tumor patients who were positive for growth-inhibitor-positive tumors in a sub-group of 360 GEP-NETs patients.
second clinical trial is part of the FDA's expanded use program, which allows patients with serious and life-threatening diseases to access new drugs for treatment.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

High Quality Pharmaceutical Intermediate API Raw Material 3,4-difluoro- CAS 2396750-32-4

CAS No.: 2396750-32-4

Industrial Grade

$700.00/G EXW

9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4

CAS No.: 1369431-34-4

Chemical Grade

$10/KG FOB

Molybdenum hexacarbonyl

CAS No.: 13939-06-5

$1/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.